GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pideka Group Inc (OTCPK:CIMVF) » Definitions » EV-to-Revenue

Pideka Group (Pideka Group) EV-to-Revenue : (As of May. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pideka Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pideka Group's enterprise value is $12.83 Mil. Pideka Group does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Sep. 2021. Therefore, GuruFocus does not calculate Pideka Group's EV-to-Revenue at this moment.

The historical rank and industry rank for Pideka Group's EV-to-Revenue or its related term are showing as below:

CIMVF's EV-to-Revenue is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.375
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-14), Pideka Group's stock price is $0.0111. Pideka Group does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2021. Therefore, GuruFocus does not calculate Pideka Group's PS Ratio at this moment.


Pideka Group EV-to-Revenue Historical Data

The historical data trend for Pideka Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pideka Group EV-to-Revenue Chart

Pideka Group Annual Data
Trend
EV-to-Revenue

Pideka Group Quarterly Data
Mar20 Jun20 Sep20 Mar21 Jun21 Sep21
EV-to-Revenue Get a 7-Day Free Trial - - - 46.42 33.30

Competitive Comparison of Pideka Group's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Pideka Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pideka Group's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pideka Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pideka Group's EV-to-Revenue falls into.



Pideka Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Pideka Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=12.829/
=


Pideka Group  (OTCPK:CIMVF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Pideka Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0111/
=


Pideka Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pideka Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Pideka Group (Pideka Group) Business Description

Traded in Other Exchanges
N/A
Address
40 King Street West, 2100 Scotia Plaza, Toronto, ON, CAN, M5H 3C2
Pideka Group Inc is multi-national operator with a medical grade indoor cultivation facility and laboratory in Colombia which holds GMP-PHARMA and good agricultural and collection practice certifications, and a retail operation in California.